Eugene Mironets

Eugene Mironets is an accomplished professional in the biotech and pharmaceutical industries, currently serving as the Associate Director of Business Development at Alloy Therapeutics, Inc. since February 2025, while also operating as an Independent Biotech and Pharma Consultant through Eugene Mironets Consulting, LLC since January 2024. Previously held positions include Senior Account Manager at bit.bio, where responsibilities spanned the East Coast and Mid-Atlantic regions, and Consultant at Alacrita Consulting, a firm specializing in life science consulting. Eugene's academic background includes postdoctoral research at the University of Pennsylvania and Drexel University College of Medicine, focusing on cannabinoid signaling related to HIV infection and the regulation of sympathetic nervous system dysfunction after central nervous system injury. Eugene Mironets holds a PhD in Neuroscience from Drexel University College of Medicine and a Bachelor's degree in Biology from the University of Connecticut.